Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Schwab US Largecap ETF | SCHX | Aug 30, 2024 | 66.65 | +0.95 |
Schwab US Largecap Growth ETF | SCHG | Aug 30, 2024 | 101.63 | +1.03 |
Schwab US Largecap Value ETF | SCHV | Aug 30, 2024 | 79.47 | +0.85 |
Schwab US Midcap ETF | SCHM | Aug 30, 2024 | 81.63 | +0.58 |
Schwab US REIT ETF | SCHH | Aug 30, 2024 | 22.59 | +0.98 |
Schwab US Smallcap ETF | SCHA | Aug 30, 2024 | 51.12 | +0.65 |
Schwab US Tips ETF | SCHP | Aug 30, 2024 | 52.93 | -0.34 |
Schweitzer-Mauduit International | MATV | Aug 30, 2024 | 18.96 | +1.44 |
Science Applications International | SAIC | Aug 30, 2024 | 130.59 | +1.06 |
Scienjoy A | SJ | Aug 30, 2024 | 0.98 | +0.41 |
Scilex | SCLX | Aug 30, 2024 | 1.15 | +3.60 |
Scinai Immunotherapeutics | SCNI | Aug 30, 2024 | 3.73 | -4.85 |
Scisparc | SPRC | Aug 30, 2024 | 0.36 | -2.39 |
Scorpio Tankers | STNG | Aug 30, 2024 | 71.54 | +1.27 |
Scotts Miracle-Gro | SMG | Aug 30, 2024 | 70.98 | -0.07 |
scPharmaceuticals | SCPH | Aug 30, 2024 | 5.09 | +0.99 |
Screaming Eagle Acquisition Unit | SCRMU | Aug 30, 2024 | 10.00 | 0.00 |
Scully Royalty | SRL | Aug 30, 2024 | 8.35 | +1.01 |
SCWorx | WORX | Aug 30, 2024 | 1.21 | +9.01 |
SCYNEXIS | SCYX | Aug 30, 2024 | 1.46 | 0.00 |
SDCL EDGE Acquisition | SEDA | Aug 30, 2024 | 11.19 | 0.00 |
Sea ADR A | SE | Aug 30, 2024 | 78.31 | +1.02 |
Seaboard | SEB | Aug 30, 2024 | 3 110.37 | +0.04 |
Seabridge Gold | SA | Aug 30, 2024 | 17.57 | -0.90 |
Seacoast Banking Corp of Florida | SBCF | Aug 30, 2024 | 27.36 | +0.48 |
SEACOR Marine | SMHI | Aug 30, 2024 | 11.45 | -0.95 |
Seadrill | SDRL | Aug 30, 2024 | 43.12 | -0.32 |
Seagate Technology | STX | Aug 30, 2024 | 99.55 | +2.06 |
Sealed Air | SEE | Aug 30, 2024 | 34.95 | +1.04 |
SEALSQ | LAES | Aug 30, 2024 | 0.59 | -2.44 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.